Top list · Worldwide · 2026
198 pharma startups that raised in 2026 have raised money in rounds we track in 2026. These are the 50 that raised the most, $10B between them, with the United States the most common home.
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Founded 2019Waltham, United States$719Mlast round Mar 2026Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Founded 2013San Carlos, United States$633Mlast round Jan 2026CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Founded 2014United States$550Mlast round Mar 2026Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Founded 2019Radnor, United States$500Mlast round Jun 2026Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Founded -Waltham, United States$380Mlast round Sept 2026Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Founded -Cambridge, United States$380Mlast round Jun 2026OMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule medicines for rare diseases and
Founded 2016Oxford, United Kingdom$363Mlast round Oct 2026Ollin Biosciences is a clinical-stage biopharmaceutical company based in Austin, Texas, founded in 2023.
Founded -Austin, United States$330Mlast round Jun 2026Beeline Medicines is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on developing precision therapies for autoimmune and inflamm
Founded 2025Stamford, United States$300Mlast round Apr 2026CellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.
Founded 2004Saffron Walden, United Kingdom$285Mlast round May 2026LB Pharmaceuticals specializes in developing a treatment for schizophrenia.
Founded 2015Menlo Park, United States$250Mlast round Jul 2026Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.
Founded -Boston, United States$225Mlast round Sept 2026Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Founded 2014Burlingame, United States$201Mlast round Jan 2026MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Founded 2018Palo Alto, United States$150Mlast round Aug 2026Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.
Founded 2018South San Francisco, United States$150Mlast round Apr 2026Matchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.
Founded 2021Cambridge, United States$150Mlast round Oct 2026Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Founded -Waltham, United States$150Mlast round Jun 2026Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Founded 2020Cambridge, United States$150Mlast round Feb 2026Latus Bio is a biotechnology company based in Philadelphia, Pennsylvania, with an additional office in Boston.
Founded 2022Philadelphia, United States$140Mlast round May 2026Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.
Founded 2013Malvern, United States$138Mlast round May 2026Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Founded 2023San Diego, United States$137Mlast round Apr 2026Omni Metalcraft provides conveyors, replacement rollers, and components to manufacturing industries.
Founded 1976Alpena, United States$135Mlast round Nov 2026Angitia Biopharmaceuticals is a clinical-stage biotechnology company founded in 2018, dedicated to developing innovative therapies for serious musculoskeletal diseases.
Founded 2018Westlake Village, United States$130Mlast round Feb 2026Diagonal Therapeutics is developing a new class of clustering antibody medicines designed to address the root causes of severe genetic diseases.
Founded 2022Watertown, United States$125Mlast round Jan 2026Cambrian is a distributed development company building therapeutics to lengthen health span.
Founded 2019New York, United States$124Mlast round Jul 2026Sling Therapeutics is a private biopharmaceutical company based in Ann Arbor, Michigan.
Founded 2020Ann Arbor, United States$123Mlast round Sept 2026Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.
Founded 2015United States$120Mlast round Oct 2026Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Founded 2011Daix, France$120Mlast round Jun 2026Claris Biotherapeutics is a late-clinical stage biotechnology company based in Jersey City, New Jersey.
Founded 2018Jersey City, United States$118Mlast round Jul 2026GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Founded 2018Dublin, Ireland$118Mlast round Apr 2026BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
Founded -Richmond, United States$115Mlast round Jan 2026Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Founded 2023Waltham, United States$100Mlast round Mar 2026Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Founded 2012Cambridge, United States$100Mlast round Mar 2026Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines.
Founded 1998Søborg (Copenhagen), Denmark$100Mlast round Aug 2026Stipple Bio is a biotechnology company based in Cambridge, Massachusetts, founded in 2022.
Founded 2022Cambridge, United States$100Mlast round Apr 2026Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Founded 2017London, United Kingdom$92Mlast round May 2026Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Founded 2016Wilmington, United States$90Mlast round Apr 2026Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Founded 2024Doylestown, United States$89Mlast round Mar 2026Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Founded -Pacific Palisades, United States$88Mlast round May 2026ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Founded 2011Lausanne, Switzerland$87Mlast round Oct 2026Ona Therapeutics is a clinical-stage biotechnology company based in the Barcelona Science Park, Spain.
Founded 2019Barcelona, Spain$87Mlast round Jun 2026Founded in 2019 and headquartered in Chengdu, China, Zenitar is a clinical-stage biotech company dedicated to advancing AI-driven, structure-based small molecul
Founded 2019Chengdu, China$86Mlast round Jan 2026Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.
Founded 2013Framingham, United States$79Mlast round Sept 2026Companies with a round in 2026 that we track, ranked by what they raised this year. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back pharma startups that raised in 2026 in the app, with filters, lists and exports.
ALNR
RBPharma startups in the United States540 companies · $23B
C
OT
APharma startups in the United Kingdom76 companies · $4.0B
DT
QPPharma startups founded in 201963 companies · $3.5B
AL
RB
MTPharma startups founded in 202160 companies · $6.3B
I
MT
8Pharma startups founded in 201858 companies · $4.5BNR
BTPharma startups founded in 202057 companies · $3.5B
IP
IT
VTPharma startups in France40 companies · $803M
M
LB
DTPharma startups founded in 202230 companies · $1.0B
GV
V
RPHealth startups worldwide12,811 companies · $81B
O
A
XAI startups worldwide10,238 companies · $830B
GV
V
RPBiotech startups worldwide7,127 companies · $70B
D
B
FTBig data startups worldwide3,812 companies · $220BAF
R
SFintech startups worldwide3,200 companies · $94B
O
A
BAI startups that raised in 20262,922 companies · $540B in 2026
FT
CE
PEnergy providers startups worldwide2,808 companies · $152B
P
OMarketing tech startups worldwide2,728 companies · $28B